Expert advises biotech firms to look at device firms' strategy

05/5/2010 | Wall Street Journal, The

Medical-device executives often adopt a clear-cut strategy when pitching their businesses to venture firms, a characteristic that should be imbibed by their biotech counterparts, said Bruce Peacock, a venture partner at SV Life Sciences. Because the "entrepreneurial therapeutics business is evolving to be like [the] entrepreneurial device business," biotech startups should focus on a couple of programs instead of concentrating on a portfolio of drug candidates, Peacock said.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY